HIC
PFE icon

Hamrick Investment Counsel’s Pfizer PFE Stock Holding History

Hamrick Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Buy
53,146
+10,340
+24% +$275K 0.83% 31
2025
Q4 		$1.07M Buy
+42,806
New +$1.08M 0.79% 36

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hamrick Investment Counsel's PFE Position: Q1 2026 in Review

Hamrick Investment Counsel increased its Pfizer (PFE) stake by 24% in Q1 2026, buying an estimated $275K and bringing the position to 53,146 shares worth $1.49M. The position accounts for 0.83% of the portfolio, ranked #31.

Hamrick Investment Counsel first reported a position in PFE in Q4 2025 and has held it in 2 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hamrick Investment Counsel held 53,146 shares of Pfizer worth $1.49M as of Q1 2026.
  • Hamrick Investment Counsel bought 10,340 Pfizer shares in Q1 2026, an estimated $275K.
  • Pfizer made up 0.83% of Hamrick Investment Counsel's portfolio in Q1 2026, its #31 holding.
  • Hamrick Investment Counsel first reported a position in Pfizer in Q4 2025 and has held it in 2 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hamrick Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.